Nova Eye Medical Limited
Nova Eye Medical Limited, headquartered in Australia, is a pioneering company in the ophthalmic medical device industry. Founded in 2017, it has quickly established itself as a leader in innovative solutions for eye care, particularly in the fields of glaucoma and cataract treatment. The company’s flagship products, including the iTrack™ and the KDB™ (Kahook Dual Blade), are renowned for their unique design and effectiveness, setting new standards in minimally invasive surgical techniques. With a strong presence in major operational regions such as North America and Europe, Nova Eye Medical has achieved significant milestones, including regulatory approvals and successful clinical outcomes that underscore its commitment to advancing eye health. Recognised for its cutting-edge technology and dedication to improving patient outcomes, Nova Eye Medical continues to solidify its market position as a trusted name in ophthalmology.
DitchCarbon Score
How does Nova Eye Medical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nova Eye Medical Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nova Eye Medical Limited's reported carbon emissions
Nova Eye Medical Limited, headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Nova Eye Medical may not have established formal sustainability initiatives or targets at this time. As the industry increasingly prioritises climate action, it will be essential for the company to consider developing strategies to address carbon emissions and enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nova Eye Medical Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
